BackAspen Aerogels Overview

Aspen Aerogels Other Current Liabilities

Track Aspen Aerogels's other current liabilities ($8.2M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$8.25M
47.00% YoYΔ $-7.32M vs prior year quarter

Peer trimmed avg / median

Loading

Aspen Aerogels Other Current Liabilities History

Loading

Aspen Aerogels vs. peers: Other Current Liabilities Comparison

Loading

Aspen Aerogels Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Aspen Aerogels (ASPN) FAQ

The latest other current liabilities for ASPN is $8.2M as of June 2026. That compares with $16M in the prior-year period — down 47.0% year over year. Investors often review this figure alongside Aspen Aerogels's historical trend and sector peers before judging valuation or financial health.

Over the past year, ASPN's other current liabilities moved from $16M to $8.2M — a 47.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Aspen Aerogels's operating scale or balance-sheet position.

A other current liabilities figure of $8.2M for ASPN is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting ASPN's other current liabilities ($8.2M), review year-over-year change from $16M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Aspen Aerogels's other current liabilities against similar Industrials names. You can also browse sector and industry screens on Stockcircle for a broader set of Industrials companies and their key multiples and fundamentals.